Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Body Mass Index Role in the Oncological Outcome of Locally Advanced Rectal Cancer: The Two BMI Extremes as Comparative Groups, A Retrospective Study

NCT04759638 is registered in ClinicalTrials.gov with King Hussein Cancer Center as lead sponsor.

NCT NCT04759638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04759638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Body Mass Index Role in the Oncological Outcome of Locally Advanced Rectal Cancer: The Two BMI Extremes as Comparative Groups, A Retrospective Study
Lead sponsor
King Hussein Cancer Center
Phase
Observational
Overall status
Completed
Start date
March 21, 2017
Completion date
March 25, 2020
Enrollment
294 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer